{"log_id": 75703106389380634, "direction": 0, "words_result_num": 76, "words_result": [{"probability": {"variance": 0.000173, "average": 0.99691, "min": 0.91339}, "location": {"width": 740, "top": 99, "height": 42, "left": 102}, "words": "1.对急性前葡萄膜炎的临床研究中发现,本品的疗效比1%的醋酸强的松龙差。因此对于需要更有效的皮"}, {"probability": {"variance": 9.5e-05, "average": 0.994363, "min": 0.964708}, "location": {"width": 351, "top": 130, "height": 31, "left": 128}, "words": "质激素治疗急性前葡萄膜炎的患者,不应使用本品"}, {"probability": {"variance": 3e-06, "average": 0.998831, "min": 0.995281}, "location": {"width": 269, "top": 156, "height": 27, "left": 132}, "words": "本品应保存在安全之处,避免儿童接触"}, {"probability": {"variance": 0.000261, "average": 0.992185, "min": 0.923689}, "location": {"width": 735, "top": 168, "height": 38, "left": 107}, "words": "孕妇及哺乳期妇女用药】动物试验显示高于本品临床每日最大剂量时家兔和大鼠会出现胚胎毒性和致畸性"}, {"probability": {"variance": 2e-06, "average": 0.99879, "min": 0.993949}, "location": {"width": 210, "top": 203, "height": 27, "left": 103}, "words": "以及母体毒性(见【药理毒理】"}, {"probability": {"variance": 8e-06, "average": 0.99818, "min": 0.987896}, "location": {"width": 488, "top": 194, "height": 29, "left": 356}, "words": "本品未在人体进行相应研究,因此孕妇慎用。目前尚未知道眼睛局部用"}, {"probability": {"variance": 0.000353, "average": 0.995451, "min": 0.872315}, "location": {"width": 739, "top": 214, "height": 39, "left": 103}, "words": "皮质类固醇是否会导致充分的全身吸收以至在母乳中产生的可检测的量。全身用药的类固醇可以出现在母乳"}, {"probability": {"variance": 3.1e-05, "average": 0.996113, "min": 0.978031}, "location": {"width": 713, "top": 239, "height": 36, "left": 104}, "words": "中,并能抑制生长,影响内源性皮质类固醇的产生或者产生其他不利的影响。因此哺乳期女性慎用本品"}, {"probability": {"variance": 0.000123, "average": 0.996365, "min": 0.938848}, "location": {"width": 454, "top": 267, "height": 30, "left": 103}, "words": "【儿童用药】目前尚无用于儿童用药的安全性和有效性的足够资料"}, {"probability": {"variance": 2.2e-05, "average": 0.996505, "min": 0.981795}, "location": {"width": 562, "top": 288, "height": 33, "left": 106}, "words": "【老年用药】目前尚无老年患者使用本品需要特别注意的事项,在权衡利弊的前提"}, {"probability": {"variance": 6e-06, "average": 0.997921, "min": 0.990335}, "location": {"width": 372, "top": 314, "height": 31, "left": 108}, "words": "药物相互作用】目前尚无有关药物的相互作用的资料"}, {"probability": {"variance": 1.1e-05, "average": 0.998351, "min": 0.984446}, "location": {"width": 357, "top": 337, "height": 30, "left": 109}, "words": "药物过量】目前尚无有关药物过量研究的足够资料"}, {"probability": {"variance": 0.000255, "average": 0.995968, "min": 0.891388}, "location": {"width": 734, "top": 352, "height": 37, "left": 110}, "words": "临床试验】采用多中心、随机、单盲、阳性药物平行对照研究,确定本品对控制白内障摘除和人工晶状体"}, {"probability": {"variance": 0.000967, "average": 0.993626, "min": 0.783342}, "location": {"width": 741, "top": 375, "height": 37, "left": 104}, "words": "植入术后炎症反应和过敏性结膜炎的有效性和安全性。研究对象为无并发症的白内障囊外或超声乳化摘除和"}, {"probability": {"variance": 7e-05, "average": 0.995929, "min": 0.963029}, "location": {"width": 738, "top": 397, "height": 38, "left": 106}, "words": "后房型人工晶状体植入术后患者,临床明确诊断的过敏性结膜炎和春季卡他性结膜炎患者。每次1滴,滴入"}, {"probability": {"variance": 6.9e-05, "average": 0.996257, "min": 0.949483}, "location": {"width": 738, "top": 419, "height": 39, "left": 105}, "words": "结膜囊,每日4次,用药14天。结果显示本品对白内障摘除及人工晶状体植入术后视物模糊、畏光、异物感"}, {"probability": {"variance": 9.3e-05, "average": 0.995639, "min": 0.951931}, "location": {"width": 741, "top": 442, "height": 38, "left": 107}, "words": "流泪、眼痛等症状,和睫状体充血、角膜水肿、角膜后沉着物、前房浮游体、房水闪光、虹膜后黏连等体征"}, {"probability": {"variance": 0.002939, "average": 0.988983, "min": 0.60957}, "location": {"width": 735, "top": 466, "height": 36, "left": 105}, "words": "的控制总疗效为88.2%,与1%泼尼松龙滴眼液的85.9%相似,无显著性统计学差异,不良反应的发生率为"}, {"probability": {"variance": 0.000224, "average": 0.994318, "min": 0.900272}, "location": {"width": 719, "top": 488, "height": 36, "left": 123}, "words": "7%;本品对过敏性结膜炎包括眼痒、流泪、异物感、不适感等症状,和分泌物、球结膜充血、眼睑和眼"}, {"probability": {"variance": 0.001136, "average": 0.990595, "min": 0.787087}, "location": {"width": 734, "top": 511, "height": 35, "left": 111}, "words": "周组织的充血水肿等体征的控制总疗效为94.4%,与1%泼尼松龙滴眼液的94.6%相似,无显著性统计学差异"}, {"probability": {"variance": 0.000626, "average": 0.990925, "min": 0.841096}, "location": {"width": 735, "top": 533, "height": 36, "left": 110}, "words": "不良反应发生率为1.3%。临床试验结果表明氯替泼诺混悬滴眼液(0.5%)对控制白内障摘除及人工晶状体"}, {"probability": {"variance": 3e-06, "average": 0.998796, "min": 0.993373}, "location": {"width": 351, "top": 565, "height": 27, "left": 108}, "words": "植入术后炎症反应和过敏性结膜炎是安全、有效的"}, {"probability": {"variance": 2e-06, "average": 0.998263, "min": 0.995808}, "location": {"width": 81, "top": 593, "height": 19, "left": 108}, "words": "【药理毒理】"}, {"probability": {"variance": 5e-06, "average": 0.99781, "min": 0.994227}, "location": {"width": 62, "top": 617, "height": 17, "left": 110}, "words": "药理作用"}, {"probability": {"variance": 6.6e-05, "average": 0.996547, "min": 0.956002}, "location": {"width": 736, "top": 620, "height": 40, "left": 109}, "words": "皮质类固醇可以抑制对不同刺激物的炎症反应,推迟和延缓愈合,并可以抑制水肿、纤维蛋白的沉积、毛"}, {"probability": {"variance": 2.5e-05, "average": 0.997536, "min": 0.970366}, "location": {"width": 737, "top": 644, "height": 38, "left": 109}, "words": "细血管的扩张、白细胞的迁移、毛细血管的增生,成纤维细胞的增殖,胶原的沉积及与炎症相关的瘢痕的形"}, {"probability": {"variance": 0.000118, "average": 0.996104, "min": 0.929899}, "location": {"width": 737, "top": 667, "height": 37, "left": 108}, "words": "成。对用于眼部的皮质类固醇作用机制,还没有被广泛接受的解释。但是皮质类固醇可以通过诱导磷脂酶"}, {"probability": {"variance": 0.000397, "average": 0.99412, "min": 0.864046}, "location": {"width": 738, "top": 690, "height": 37, "left": 113}, "words": "A2抑制蛋白发挥作用,所以被称为脂皮质素。这些蛋白可以有效地控制炎症介质的生物合成,例如通过抑"}, {"probability": {"variance": 1.5e-05, "average": 0.997875, "min": 0.981281}, "location": {"width": 736, "top": 713, "height": 36, "left": 109}, "words": "制它们相同前体物质花生四烯酸的释放,从而抑制前列腺素和白细胞三烯的生物合成。花生四烯酸是通过"}, {"probability": {"variance": 9.1e-05, "average": 0.995709, "min": 0.955745}, "location": {"width": 738, "top": 734, "height": 38, "left": 110}, "words": "磷脂酶从细胞膜的磷脂中被释放出来的。皮质类固醇能够升高眼内压。氯替泼诺在结构上与其他皮质类固"}, {"probability": {"variance": 6.7e-05, "average": 0.995112, "min": 0.969276}, "location": {"width": 741, "top": 758, "height": 36, "left": 109}, "words": "醇类相似,但是它在20号位置上没有酮基且它有高脂溶性,可以增强对细胞的渗透性。由于氯替泼诺是通"}, {"probability": {"variance": 7e-06, "average": 0.998365, "min": 0.985233}, "location": {"width": 740, "top": 781, "height": 36, "left": 109}, "words": "过对强的松龙类化合物进行结构改造的基础上合成的,因此它会经过一个可预测的转变而成为一种没有活"}, {"probability": {"variance": 0.000111, "average": 0.997554, "min": 0.932789}, "location": {"width": 622, "top": 806, "height": 34, "left": 110}, "words": "性的代谢产物。基于体内和体外的临床前代谢研究,被广泛代谢为无活性的羧基代谢产物"}, {"probability": {"variance": 1.1e-05, "average": 0.997359, "min": 0.991624}, "location": {"width": 61, "top": 841, "height": 18, "left": 111}, "words": "毒理研究"}, {"probability": {"variance": 0.000754, "average": 0.989982, "min": 0.852104}, "location": {"width": 740, "top": 847, "height": 38, "left": 110}, "words": "致癌性:还未进行过长期动物实验来评估氯替泼诺的潜在致癌性。氯替泼诺在体外的Ames试验中、在小鼠"}, {"probability": {"variance": 5.5e-05, "average": 0.996122, "min": 0.965654}, "location": {"width": 738, "top": 873, "height": 33, "left": 111}, "words": "淋巴瘤t试验中、在人类淋巴细胞染色体畸变试验中、或者是在体单剂量小鼠微核试验中都没有表现出遗"}, {"probability": {"variance": 0, "average": 0.999708, "min": 0.999351}, "location": {"width": 46, "top": 909, "height": 17, "left": 112}, "words": "传毒性"}, {"probability": {"variance": 0.000628, "average": 0.991871, "min": 0.842006}, "location": {"width": 734, "top": 915, "height": 36, "left": 111}, "words": "生殖毒性:兔在器官形成期经口给予氯替泼诺,剂量为3mg/kg天(临床每日最大剂量的35倍),显示出"}, {"probability": {"variance": 0.000229, "average": 0.996441, "min": 0.894651}, "location": {"width": 742, "top": 938, "height": 35, "left": 111}, "words": "胎毒性(使骨化延迟)和致畸性(增加了脑膜突出、左颈总动脉的异常、四肢屈曲畸形的发生率),但该剂"}, {"probability": {"variance": 0.001385, "average": 0.984922, "min": 0.793977}, "location": {"width": 711, "top": 963, "height": 32, "left": 112}, "words": "量对母体没有毒性。未观测到(毒性)的效应水平(NOEL)是0.5mg/kg/天(临床最大每日剂量的6倍"}, {"probability": {"variance": 0.000726, "average": 0.990772, "min": 0.871418}, "location": {"width": 343, "top": 991, "height": 27, "left": 116}, "words": "在器官形成期给予大鼠口服药物,结果出现致畸性"}, {"probability": {"variance": 0.005076, "average": 0.979259, "min": 0.678722}, "location": {"width": 262, "top": 986, "height": 24, "left": 517}, "words": "g/kg/天的剂量出现无名动脉缺失,在"}, {"probability": {"variance": 0.002891, "average": 0.944737, "min": 0.890974}, "location": {"width": 16, "top": 989, "height": 17, "left": 822}, "words": "/k"}, {"probability": {"variance": 0.000708, "average": 0.988754, "min": 0.871523}, "location": {"width": 728, "top": 1008, "height": 33, "left": 117}, "words": "天的剂量出现颚裂和脐疝)以及胚胎毒性(在100mg/kg天的剂量增加了着床后流产的发生,在≥50mg/kg"}, {"probability": {"variance": 0.00062, "average": 0.992028, "min": 0.87222}, "location": {"width": 392, "top": 1036, "height": 26, "left": 118}, "words": "天的剂量减少了胎儿体重和骨骼骨化)。在器官形成期给"}, {"probability": {"variance": 7e-06, "average": 0.997993, "min": 0.989658}, "location": {"width": 240, "top": 1030, "height": 24, "left": 589}, "words": "kg天的剂量(临床最大剂量的6倍"}, {"probability": {"variance": 0.000709, "average": 0.990926, "min": 0.852411}, "location": {"width": 732, "top": 1053, "height": 33, "left": 112}, "words": "没有发生任何生殖毒性。当妊娠的大鼠在胎儿器官形成期给予≥5mg/kg天的剂量时,结果体现出母体毒性"}, {"probability": {"variance": 0.000232, "average": 0.992711, "min": 0.9413}, "location": {"width": 227, "top": 1084, "height": 24, "left": 117}, "words": "在给药期间的体重增加显著减少"}, {"probability": {"variance": 0.000246, "average": 0.994768, "min": 0.895108}, "location": {"width": 736, "top": 1095, "height": 36, "left": 117}, "words": "药代动力学】在健康志愿者身上进行的生物利用度研究结果发现,在所有的抽样时间点上,氯替泼诺和"}, {"probability": {"variance": 0.000137, "average": 0.994923, "min": 0.939907}, "location": {"width": 654, "top": 1119, "height": 32, "left": 202}, "words": "酸碳酸乙酯(PJ91)(氯替泼诺最初的没有活性的代谢产物)的血浆水平都低于定量检测"}, {"probability": {"variance": 0.000311, "average": 0.99308, "min": 0.920215}, "location": {"width": 624, "top": 1141, "height": 31, "left": 228}, "words": "这个结果是通过以下用法得到的:用0.5%的氯替泼诺在每只眼中滴一滴,每天八次持续2"}, {"probability": {"variance": 3.8e-05, "average": 0.997822, "min": 0.963176}, "location": {"width": 566, "top": 1167, "height": 30, "left": 115}, "words": "天或每天4次持续42天。这项研究提示,使用本品时发生的全身性的吸收是有限的"}, {"probability": {"variance": 0.000893, "average": 0.990379, "min": 0.843241}, "location": {"width": 371, "top": 1193, "height": 25, "left": 117}, "words": "【贮藏】本品应于15-25℃下竖直放置储存,不能冷冻"}, {"probability": {"variance": 0.001306, "average": 0.98371, "min": 0.841072}, "location": {"width": 306, "top": 1217, "height": 24, "left": 117}, "words": "【包装】本品由塑料瓶包装,5m/瓶,1瓶/盒"}, {"probability": {"variance": 1e-05, "average": 0.997931, "min": 0.990372}, "location": {"width": 118, "top": 1242, "height": 18, "left": 124}, "words": "有效期】24个月"}, {"probability": {"variance": 5e-06, "average": 0.998046, "min": 0.991802}, "location": {"width": 206, "top": 1261, "height": 25, "left": 113}, "words": "【执行标准】进口药品注册标"}, {"probability": {"variance": 0.000531, "average": 0.987071, "min": 0.935954}, "location": {"width": 79, "top": 1288, "height": 18, "left": 112}, "words": "【批准文号】"}, {"probability": {"variance": 1.5e-05, "average": 0.997609, "min": 0.987805}, "location": {"width": 203, "top": 1308, "height": 20, "left": 117}, "words": "进口药品注册证号:H20110"}, {"probability": {"variance": 0.0003, "average": 0.992008, "min": 0.93392}, "location": {"width": 273, "top": 1327, "height": 26, "left": 117}, "words": "进口药品大包装注册证号:H20140895"}, {"probability": {"variance": 0.000109, "average": 0.995357, "min": 0.95654}, "location": {"width": 243, "top": 1350, "height": 26, "left": 114}, "words": "分包装药品批准文号:国药准字J2"}, {"probability": {"variance": 3.5e-05, "average": 0.99588, "min": 0.984118}, "location": {"width": 78, "top": 1377, "height": 18, "left": 118}, "words": "【生产企业"}, {"probability": {"variance": 0, "average": 0.99976, "min": 0.9993}, "location": {"width": 65, "top": 1399, "height": 18, "left": 116}, "words": "生产企业"}, {"probability": {"variance": 0.00034, "average": 0.963745, "min": 0.945302}, "location": {"width": 13, "top": 1399, "height": 16, "left": 231}, "words": "ch"}, {"probability": {"variance": 0.000701, "average": 0.985874, "min": 0.922543}, "location": {"width": 95, "top": 1422, "height": 18, "left": 115}, "words": "生产地址:85"}, {"probability": {"variance": 0, "average": 0.999603, "min": 0.998678}, "location": {"width": 78, "top": 1444, "height": 18, "left": 116}, "words": "分包装企业"}, {"probability": {"variance": 0.001431, "average": 0.988718, "min": 0.829869}, "location": {"width": 299, "top": 1460, "height": 26, "left": 117}, "words": "企业名称:山东博士伦福瑞达制药有限公司"}, {"probability": {"variance": 3e-05, "average": 0.994386, "min": 0.986738}, "location": {"width": 196, "top": 1432, "height": 55, "left": 799}, "words": "广州医"}, {"probability": {"variance": 0.000337, "average": 0.992655, "min": 0.920147}, "location": {"width": 346, "top": 1481, "height": 28, "left": 117}, "words": "生产地址:济南市高新技术开发区新泺大街789号"}, {"probability": {"variance": 0.000632, "average": 0.978093, "min": 0.94287}, "location": {"width": 184, "top": 1471, "height": 36, "left": 851}, "words": "有限公"}, {"probability": {"variance": 6.6e-05, "average": 0.996922, "min": 0.96154}, "location": {"width": 345, "top": 1505, "height": 25, "left": 115}, "words": "注册地址:济南市高新技术开发区新泺大街789号"}, {"probability": {"variance": 0.000234, "average": 0.99357, "min": 0.930426}, "location": {"width": 259, "top": 1529, "height": 23, "left": 116}, "words": "邮政编码:250101电话号码:(053"}, {"probability": {"variance": 1e-06, "average": 0.999184, "min": 0.997573}, "location": {"width": 90, "top": 1525, "height": 19, "left": 458}, "words": "91传真号码"}, {"probability": {"variance": 0, "average": 0.983024, "min": 0.983024}, "location": {"width": 17, "top": 1556, "height": 16, "left": 120}, "words": "网"}, {"probability": {"variance": 0, "average": 0.952262, "min": 0.952262}, "location": {"width": 15, "top": 1555, "height": 14, "left": 294}, "words": " cn"}, {"probability": {"variance": 0.001177, "average": 0.986034, "min": 0.883523}, "location": {"width": 146, "top": 1576, "height": 20, "left": 117}, "words": "博士伦服务热线:40"}, {"probability": {"variance": 0.010646, "average": 0.93736, "min": 0.758653}, "location": {"width": 105, "top": 1604, "height": 39, "left": 1073}, "words": "仅供存档"}], "language": -1}